European Archives - Page 776 of 1389 - European Medical Journal

The changing rhythm of digital therapeutics

Digital therapeutics are making their way onto the main stage, and pharma should be taking note. What lies ahead for potential partnerships?

EMJ Dermatology 10 [Infographic Supplement 2] 2022 Feature Image

EMJ Dermatology 10 [Infographic Supplement 2] 2022

Key learnings from a satellite symposium at the 9th Psoriasis: From Gene to Clinic Congress are summarised in an infographic exploring evolving understanding of IL-23 pathway inhibition in the treatment of psoriasis and psoriatic arthritis (PsA).

Joining the Conversation on Our Evolving Understanding of Psoriasis and PSA Management Strategies: IL-23 Pathway Inhibition

Learnings from the Janssen-Sponsored Hybrid Satellite Symposium at the 9th Psoriasis: from Gene to Clinic Congress on 10 December 2021

Urgent Support and Aid Needed for Ukrainian Patients with Rare Diseases and their Families

The urgent need regarding people with a rare disease in Ukraine is for help to get vulnerable families safely out of the country and help…

What is New and What is Coming with Neurotoxins

This webinar will discuss the latest developments and advances in the use of botulinum toxins within the cosmetic/aesthetic space. In light of the rapid growth in the cosmetic/aesthetic industry mainly linked to the use of botulinum toxin, the speaker will also cover new toxins and their use and application in cosmetic medicine.

International Women’s Day special

In this special bumper episode, GOLD celebrates International Women’s Day by speaking to Nikki Jones (HBA) and Aliya Omer (Kite Pharma) about the role of women in pharma industry.

Infographic: Rosacea Awareness

Rosacea is a skin condition that commonly causes red patches and dry skin on the face. This infographic raises awareness in this long-term condition, sharing subtypes, epidemiology, and treatment.

Direct Oral Anticoagulants in the Treatment of Cancer-Related Venous Thromboembolism: Patient Cases

In this episode, we have two experts in the field of direct oral anticoagulants for the treatment of cancer related venous thromboembolisms.

The Challenging Ethical Landscape of NAFLD

Management of NAFLD is not as straightforward as it first looks. There is no virus to suppress, no single behaviour to modify, no easy prescription, and no straightforward route to transplantation.

EMJ Oncology 10 [Supplement 5] 2022 Feature Image

Implementation of MET Molecular Testing in the Clinic: Latest Evidence for Mesenchymal–Epithelial Transition Inhibitors in Non-small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a heterogeneous disease with many genomic mutations. Furthermore, comprehensive genomic…